NCT04560413|Completed
Loading search results
Sponsor study identifier
observational
77
1 country
1
Study Start
June 1, 2020
Actual (reported)Primary Completion
July 25, 2020
Actual (reported)Study Completion
August 10, 2020
Actual (reported)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has begun, first in Wuhan, China, and then became a pandemic. The first SARS-CoV-2 case in Turkey was reported on March 11, 2020. People older than 65 years old became subject to lock down measures beginning on March 21, while people younger than 20 years old became subject to lock down measures beginning on April 03. A total lock down has been implemented a few times lasting between 3 to 4 days, especially at weekends. Several studies show that mental health problems could occur in public during the SARS-CoV-2 pandemic. Depression and anxiety are a commonly known mental health issue in post-stroke patients. This patient population, who usually have to spend most of their time at home, remained completely at home and socially isolated due to the precautions required by the pandemic. Based on the above research evidence; depression, anxiety and phobia of SARS-CoV-2 may increase in the post stroke patients due to being in risk group and effects of measures taken against SARS-CoV-2 pandemic. Therefore, we aimed to assess the depression, anxiety and SARS-CoV-2 phobia in post stroke patients during SARS-CoV-2 outbreak, and to explore the potential influence factors.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 10, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 1, 2020
Actual (reported)July 25, 2020
Actual (reported)August 10, 2020
Actual (reported)September 20, 2020
Actual (reported)September 23, 2020
Actual (reported)Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale evaluation includes a total of 14 questions (score range 0-3), which are scored to separately estimate anxiety and depressive status (7 questions each). The individual score for the anxiety and depression subscales may vary from 0 to 21. The aim of this scoring system is not to make an objective diagnosis, but to determine the current presence and tendency to anxiety or depression at the time of diagnosis. A HADS score of 8 to 10 is broadly accepted as indicating mild symptoms, a score between 11-16 suggests moderate anxiety or depression, and a score of 16 or more indicates severe anxiety or depressive symptoms
3 months
Covid 19 Phobia Scale
The Covid 19 Phobia Scale is a self-report instrument with a five-point Likert-type scale to assess the levels of SARS-CoV-2 phobia. All items are rated on a 5-point scale from "strongly disagree (1)" to "strongly agree (5)." The scores on the scale can range between 20 and 100 and a higher score indicates a greater phobia in the respected subscales and total scale. In the present study total scale scores ranged from 20 to 100. The scale examines four main factors: psychological, psycho-somatic, economic and social
3 months
Post-stroke patients who aged over 18
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, 34752, Turkey (Türkiye)
Duygu Silte Karamanlioglu, MD
Fatih Sultan Mehmet Training and Research Hospital
Arzu Atici, MD
Fatih Sultan Mehmet Training and Research Hospital
Gulcan Ozturk, MD
Fatih Sultan Mehmet Training and Research Hospital
Pinar Akpinar, Assoc Prof
Fatih Sultan Mehmet Training and Research Hospital
77 participants (actual enrollment reported by the registry).
First Submitted
September 20, 2020
First Posted
September 23, 2020
Study Start
June 1, 2020
Actual (reported)Contact the study team to confirm eligibility.
Feyza Unlu Ozkan, Assoc Prof
Fatih Sultan Mehmet Training and Research Hospital
Ilknur Aktas, Prof
Fatih Sultan Mehmet Training and Research Hospital
Primary Completion
July 25, 2020
Actual (reported)Study Completion
August 10, 2020
Actual (reported)Last Updated
September 30, 2020
Record last verified: 2020-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: